Should all Pima Indians with type 2 diabetes mellitus be prescribed routine angiotensin-converting enzyme inhibition therapy to prevent renal failure?

Bryce A. Kiberd; Kailash K. Jindal

doi:10.4065/74.6.559

Should all Pima Indians with type 2 diabetes mellitus be prescribed routine angiotensin-converting enzyme inhibition therapy to prevent renal failure?

Bryce A. Kiberd, Kailash K. Jindal

Biochemistry, Genetics and Molecular Biology

Research output: Contribution to journal › Article › peer-review

12 Citations (Scopus)

Original language	English
Pages (from-to)	559-564
Number of pages	6
Journal	Mayo Clinic Proceedings
Volume	74
Issue number	6
DOIs	https://doi.org/10.4065/74.6.559
Publication status	Published - 1999

ASJC Scopus Subject Areas

General Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.4065/74.6.559

Cite this

@article{8c93ad54be5343e1990f2d2ebe61cdd9,

title = "Should all Pima Indians with type 2 diabetes mellitus be prescribed routine angiotensin-converting enzyme inhibition therapy to prevent renal failure?",

author = "Kiberd, {Bryce A.} and Jindal, {Kailash K.}",

year = "1999",

doi = "10.4065/74.6.559",

language = "English",

volume = "74",

pages = "559--564",

journal = "Mayo Clinic Proceedings",

issn = "0025-6196",